VIVA Biotech Holdings
HKEX:1873
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
CN |
|
Grupo Mateus SA
BOVESPA:GMAT3
|
BR |
|
G
|
Ganfeng Lithium Co Ltd
HKEX:1772
|
CN |
|
B
|
Best Pacific International Holdings Ltd
HKEX:2111
|
CN |
|
O
|
Openbase Inc
KOSDAQ:049480
|
KR |
|
A
|
Aurrigo International PLC
LSE:AURR
|
UK |
|
Z
|
ZJK Industrial Co Ltd
NASDAQ:ZJK
|
CN |
|
Chobi Co Ltd
KRX:001550
|
KR |
|
Haseko Corp
TSE:1808
|
JP |
|
Nordic Financials ASA
OSE:NOFIN
|
NO |
|
V
|
Vishay Precision Group Inc
NYSE:VPG
|
US |
|
Kindcard Inc
OTC:KCRD
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIVA Biotech Holdings's stock price target?
Not Available
VIVA Biotech Holdings doesn't have any price targets made by Wall Street professionals.
What is VIVA Biotech Holdings's Revenue forecast?
Projected CAGR
73%
For the last 7 years the compound annual growth rate for VIVA Biotech Holdings's revenue is 45%. The projected CAGR for the next 1 year is 73%.
What is VIVA Biotech Holdings's Operating Income forecast?
Projected CAGR
112%
For the last 7 years the compound annual growth rate for VIVA Biotech Holdings's operating income is 22%. The projected CAGR for the next 1 year is 112%.
What is VIVA Biotech Holdings's Net Income forecast?
Projected CAGR
209%
For the last 7 years the compound annual growth rate for VIVA Biotech Holdings's net income is 12%. The projected CAGR for the next 1 year is 209%.
